Pharmaceutical Commerce

Pharmaceutical Commerce is a publication aimed at biopharma executives who make key business decisions. It highlights the processes and technologies that play a role in bringing approved drugs to market. Our editorial content is designed to enhance teamwork among management professionals, ultimately aiming to lower the costs associated with commercial operations.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1895227

United States

#766329

Health/Biotechnology and Pharmaceuticals

#734

Traffic sources

Monthly visitors

Articles

Pharma Pulse 6/5/25: Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma

3 days ago | pharmaceuticalcommerce.com | Don Tracy

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy UtilizationA Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like cystic fibrosis—by providing faster access to treatment, better medication adherence, and personalized support that addresses the complex challenges of managing lifelong conditions.
The Tariff Effect: Greater Supply Chain Prepares for Repercussions

4 days ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Key TakeawaysTariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US drug prices by up to 12.9% and cost the industry an estimated $51 billion annually. Supply chain disruption is growing: Pharma and medtech sectors face significant supply chain strain, including delays and pricing spikes, due to tariff volatility and reliance on global manufacturing.
Pharma Pulse 6/4/25: Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens

4 days ago | pharmaceuticalcommerce.com | Don Tracy

Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve ThemIn a Pharmaceutical Executive feature, Gen Li, founder, CEO, Phesi, outlines five key challenges hindering investigator site selection in clinical trials—including unreliable performance predictions and lack of real-world data—and explains how clinical data science and AI-driven tools can optimize site feasibility, reduce costs, and accelerate drug development.
Overcoming Legacy Systems

5 days ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies experience “paralysis by analysis” due to the rapidly evolving technology landscape.
Pharma Pulse 6/3/25: Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health

5 days ago | pharmaceuticalcommerce.com | Don Tracy

Preparing for the Pharma C-SuiteIn a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how her early roles at Morgan Stanley and Deloitte Consulting, combined with strategic career decisions and authentic leadership development, prepared her for biotechnology C-suite success and offers MBA students key advice on culture fit, building healthcare connections, and leveraging their education to shape fulfilling leadership paths.
Amplifying Workforce Development

6 days ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies experience “paralysis by analysis” due to the rapidly evolving technology landscape.
Bora Expands Baltimore Facility, Adds Automated Fill-Finish Line

6 days ago | pharmaceuticalcommerce.com | Nicholas Saraceno

Key TakeawaysTo meet rising demand, Bora Pharmaceuticals is expanding its Baltimore facility by installing an automated vial, syringe, and cartridge line by 2026, enhancing its capabilities for small-scale, high-value drug production. The expansion supports increased demand for fill-finish services related to potent drugs and treatments for rare and orphan diseases, boosting Bora’s flexibility and scalability across clinical and commercial projects.
Being Digitally Optimized

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies experience “paralysis by analysis” due to the rapidly evolving technology landscape.
How Recent Executive Orders Impact the Drug Pricing Landscape

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In this exclusive PC Podcast interview, Alice Valder Curran, partner at Hogan Lovells, explores: How recent executive orders—both under the Biden and Trump administrations—have reshaped the drug pricing landscape, and the legal challenges or uncertainties they present for pharmaceutical companies What life sciences companies should be doing now to proactively prepare for further executive action on drug pricing and market access The key differences in how executive policies versus legislative...
Bridging the GenAI Adoption Gap in Supply Chain

1 week ago | pharmaceuticalcommerce.com | Nicholas Saraceno

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies experience “paralysis by analysis” due to the rapidly evolving technology landscape.